These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4795758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of pyroxamidine and guanethidine on contractile responses to field stimulation and to noradrenaline in the anococcygeus muscle and vas deferens of the rat.
    Doggrell SA.
    J Pharm Pharmacol; 1979 Nov; 31(11):767-72. PubMed ID: 41909
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of oxytocin on the isolated vas deferens of the rat.
    Beneit JV, Hidalgo A, Tamargo JL.
    Br J Pharmacol; 1980 Jul; 69(3):379-82. PubMed ID: 7397448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 6-Nitrodopamine is an endogenous mediator of rat isolated epididymal vas deferens contractions induced by electric-field stimulation.
    Britto-Júnior J, Ximenes L, Ribeiro A, Fregonesi A, Campos R, Ricardo de Almeida Kiguti L, Mónica FZ, Antunes E, De Nucci G.
    Eur J Pharmacol; 2021 Nov 15; 911():174544. PubMed ID: 34606837
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.
    Allawi HS, Wallace P, Pitcher A, Gaffen Z, Bland-Ward PA, Moore PK.
    Br J Pharmacol; 1994 Sep 15; 113(1):282-8. PubMed ID: 7529112
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methyldopa abolishes neurally evoked contractions of the vas deferens in vitro.
    Tayo FM.
    Arch Int Pharmacodyn Ther; 1979 Apr 15; 238(2):187-95. PubMed ID: 475507
    [Abstract] [Full Text] [Related]

  • 11. Vas deferens smooth muscle responses to the nitric oxide-independent soluble guanylate cyclase stimulator BAY 41-2272.
    da Silva FH, Claudino MA, Báu FR, Rojas-Moscoso JA, Mónica FZ, De Nucci G, Antunes E.
    Eur J Pharmacol; 2012 Aug 05; 688(1-3):49-55. PubMed ID: 22634166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of rubidium on responses of rabbit vas deferens to transmural stimulation and to noradrenaline.
    Johns A, Paton DM.
    Eur J Pharmacol; 1976 Jan 05; 35(1):145-50. PubMed ID: 943289
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors affecting the contractile responses of the rat vas deferens to cocaine and tetracaine.
    Vohra MM.
    Can J Physiol Pharmacol; 1970 Jul 05; 48(7):490-7. PubMed ID: 5430354
    [No Abstract] [Full Text] [Related]

  • 18. Effects of prazosin and phentolamine on responses to field stimulation and to noradrenaline in vas deferens and anococcygeus muscle of the rat.
    Doggrell SA, Paton DM.
    Arch Int Pharmacodyn Ther; 1978 Jun 05; 233(2):209-20. PubMed ID: 686912
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.